Keywords: Sanofi-Aventis, Multaq, Liver failure, Safety, Anti-arrythmic

US FDA warns on acute liver failure with Sanofi-Aventis Multaq

Article | 17 January 2011

Print This

The US Food and Drug Administration on Friday notified health care professionals and patients about cases of rare, but severe ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in